XBiotech Ownership | Who Owns XBiotech?

XBiotech Ownership Summary

XBiotech is owned by 1.34% institutional investors, 24.33% insiders, and 74.33% retail investors. Blackrock is the largest institutional shareholder, holding 3.73% of XBIT shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.04% of its assets in XBiotech shares.

XBIT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	XBiotech	1.34%	24.33%	74.33%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Biotech Stocks	35.75%	11.83%	52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	1.13M	3.73%	$5.83M
Vanguard group	299.56K	0.98%	$715.94K
Blackrock funding, inc. /de	293.10K	0.96%	$688.79K
Geode capital management	231.02K	0.76%	$543.17K
Rbf capital	198.50K	0.65%	$466.48K
Morgan stanley	165.55K	0.54%	$389.05K
Millennium management	105.54K	0.35%	$248.02K
Bridgeway capital management	98.45K	0.32%	$231.35K
Vanguard fiduciary trust	91.58K	0.30%	$215.20K
Northern trust	76.09K	0.25%	$178.80K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Rbf capital	198.50K	0.02%	$466.48K
Bridgeway capital management	98.45K	0.00%	$231.35K
Point72 asia (singapore) pte.	6.82K	0.00%	$18.13K
Thomasville national bank	13.35K	0.00%	$31.91K
Empowered funds	59.55K	0.00%	$139.94K
Xtx topco	17.90K	0.00%	$42.07K
Synovus financial	11.80K	0.00%	$31.38M
Connor, clark & lunn investment management	28.66K	0.00%	$67.36K
Mcilrath & eck	753.00	0.00%	$1.80K
Blackrock	1.13M	0.00%	$5.83M

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	1.13M	0.00%	827.52K
Vanguard fiduciary trust	91.58K	0.00%	91.58K
Renaissance	22.44K	0.00%	22.44K
Susquehanna group, llp	12.77K	-	12.77K
Geode capital management	231.02K	-	9.90K

Top Sellers

Holder	Shares	% Assets	Change
Vanguard group	299.56K	-	-519.68K
Ameriprise financial	-	-	-186.80K
Charles schwab investment management	-	-	-67.36K
Y-intercept (hong kong)	-	-	-47.88K
Deutsche bank ag\	-	-	-30.34K

New Positions

Holder	Shares	% Assets	Change	Value
Vanguard fiduciary trust	91.58K	0.00%	91.58K	$215.20K
Renaissance	22.44K	0.00%	22.44K	$52.73K
Susquehanna group, llp	12.77K	-	12.77K	$50.43K
Group one trading	7.50K	0.00%	7.50K	$29.63M
Vanguard global advisers	7.01K	-	7.01K	$16.47K

Sold Out

Holder	Change
Capital performance advisors llp	-1.00
Barclays	-1.00
Ifp advisors	-2.00
True wealth design	-3.00
Citigroup	-12.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	9	-77.50%	408,710	-82.19%	1	2.37%	5	-61.54%	4	-73.33%
Dec 31, 2025	22	-51.11%	1,433,403	-51.16%	4	5.07%	6	-62.50%	9	-50.00%
Sep 30, 2025	30	-37.50%	1,945,494	-38.93%	6	5.84%	9	-64.00%	13	-23.53%
Jun 30, 2025	51	-5.56%	3,415,938	-23.72%	11	5.19%	27	58.82%	18	-18.18%
Mar 31, 2025	54	-	4,494,575	-4.70%	14	6.15%	18	-37.93%	21	110.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	623.36K	2.04%	-
Vanguard Total Stock Mkt Idx Inv	610.02K	2.00%	-13.33K
Vanguard Institutional Extnd Mkt Idx Tr	200.97K	0.66%	-
iShares Russell 2000 Value ETF	196.42K	0.64%	-
Fidelity Small Cap Index	195.37K	0.64%	-
Fidelity Extended Market Index	110.91K	0.36%	9.27K
Vanguard Russell 2000 ETF	99.83K	0.33%	901.00
State St Russell Sm Cap® Indx SL Cl I	90.50K	0.30%	-
EA Bridgeway Omni Small-Cap Value ETF	59.55K	0.20%	-
Schwab Small Cap Index	56.88K	0.19%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 03, 2024	SIMARD JOHN	Chief Executive Officer	Buy	$10.00M
Oct 18, 2021	SIMARD JOHN	Chief Executive Officer	Sell	$431.25K
Oct 15, 2021	SIMARD JOHN	Chief Executive Officer	Sell	$226.47K
Oct 13, 2021	SIMARD JOHN	Chief Executive Officer	Sell	$139.53K
Oct 12, 2021	SIMARD JOHN	Chief Executive Officer	Sell	$229.94K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q2	-	-
2024 Q1	1	-
2023 Q3	-	-
2023 Q2	-	-

XBIT Ownership FAQ

Who Owns XBiotech?

XBiotech shareholders are primarily institutional investors at 1.34%, followed by 24.33% insiders and 74.33% retail investors. The average institutional ownership in XBiotech's industry, Biotech Stocks , is 35.75%, which XBiotech falls below.

Who owns the most shares of XBiotech?

XBiotech’s largest shareholders are Blackrock (1.13M shares, 3.73%), Vanguard group (299.56K shares, 0.98%), and Blackrock funding, inc. /de (293.1K shares, 0.96%). Together, they hold 5.67% of XBiotech’s total shares outstanding.

Does Blackrock own XBiotech?

Yes, BlackRock owns 3.73% of XBiotech, totaling 1.13M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 5.83M$. In the last quarter, BlackRock increased its holdings by 827.52K shares, a 269.88% change.

Who is XBiotech’s biggest shareholder by percentage of total assets invested?

Rbf capital is XBiotech’s biggest shareholder by percentage of total assets invested, with 0.02% of its assets in 198.5K XBiotech shares, valued at 466.48K$.

Who is the top mutual fund holder of XBiotech shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of XBiotech shares, with 2.04% of its total shares outstanding invested in 623.36K XBiotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools